ALT
Price
$4.76
Change
-$0.14 (-2.86%)
Updated
Jul 3 closing price
Capitalization
386.07M
32 days until earnings call
SRRK
Price
$35.99
Change
+$0.44 (+1.24%)
Updated
Jul 3 closing price
Capitalization
3.42B
31 days until earnings call
Interact to see
Advertisement

ALT vs SRRK

Header iconALT vs SRRK Comparison
Open Charts ALT vs SRRKBanner chart's image
Altimmune
Price$4.76
Change-$0.14 (-2.86%)
Volume$6.33M
Capitalization386.07M
Scholar Rock Holding
Price$35.99
Change+$0.44 (+1.24%)
Volume$481.99K
Capitalization3.42B
ALT vs SRRK Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. SRRK commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and SRRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ALT: $4.76 vs. SRRK: $35.99)
Brand notoriety: ALT and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 100% vs. SRRK: 39%
Market capitalization -- ALT: $386.07M vs. SRRK: $3.42B
ALT [@Biotechnology] is valued at $386.07M. SRRK’s [@Biotechnology] market capitalization is $3.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while SRRK’s TA Score has 5 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 5 bearish.
  • SRRK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALT and SRRK are a good buy in the short-term.

Price Growth

ALT (@Biotechnology) experienced а +31.86% price change this week, while SRRK (@Biotechnology) price change was +1.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.42B) has a higher market cap than ALT($386M). SRRK YTD gains are higher at: -16.728 vs. ALT (-33.981). ALT has higher annual earnings (EBITDA): -90.75M vs. SRRK (-268.99M). SRRK has more cash in the bank: 364M vs. ALT (150M). ALT has less debt than SRRK: ALT (1.59M) vs SRRK (63.1M). ALT has higher revenues than SRRK: ALT (20K) vs SRRK (0).
ALTSRRKALT / SRRK
Capitalization386M3.42B11%
EBITDA-90.75M-268.99M34%
Gain YTD-33.981-16.728203%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash150M364M41%
Total Debt1.59M63.1M3%
FUNDAMENTALS RATINGS
ALT vs SRRK: Fundamental Ratings
ALT
SRRK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6436
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRRK's Valuation (66) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that SRRK’s stock grew similarly to ALT’s over the last 12 months.

SRRK's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that SRRK’s stock grew similarly to ALT’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as SRRK (98) in the Biotechnology industry. This means that ALT’s stock grew similarly to SRRK’s over the last 12 months.

SRRK's Price Growth Rating (36) in the Biotechnology industry is in the same range as ALT (64) in the Miscellaneous Commercial Services industry. This means that SRRK’s stock grew similarly to ALT’s over the last 12 months.

SRRK's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that SRRK’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTSRRK
RSI
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 19 days ago
88%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTAFF49.371.92
+4.05%
British American Tobacco p.l.c.
ENMHF0.03N/A
N/A
ENM Holdings, Ltd.
SGHIF1.57N/A
N/A
Shanghai Industrial Holdings Ltd.
IDDWF26.45N/A
N/A
Indutrade AB
MBHCF1.00N/A
N/A
MBH Corporation PLC

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-2.86%
CRNX - ALT
50%
Loosely correlated
+1.22%
INDP - ALT
44%
Loosely correlated
+2.78%
VERA - ALT
39%
Loosely correlated
+1.48%
INZY - ALT
38%
Loosely correlated
N/A
KROS - ALT
38%
Loosely correlated
+0.30%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with PLRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
+1.24%
PLRX - SRRK
40%
Loosely correlated
+5.00%
SNDX - SRRK
39%
Loosely correlated
N/A
VTGN - SRRK
39%
Loosely correlated
-1.96%
ALT - SRRK
37%
Loosely correlated
-2.86%
AVXL - SRRK
37%
Loosely correlated
+2.08%
More